{{多個問題|
{{Expand language|en|time=2017-02-04}}
{{expand|time=2012-07-26T05:46:13+00:00}}
{{nofootnotes|time=2010-06-15T06:39:13+00:00}}
}}
{{medical}}
{{drugbox
| IUPAC_name = 4,4'-(3''E'')-hex-3-ene-3,4-diyldiphenol
| image = Diethylstilbestrol structure.svg
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 56-53-1
| ChemSpiderID = 395306
| ATC_prefix = G03
| ATC_suffix = CB02
| ATC_supplemental = {{ATC|G03|CC05}}, {{ATC|L02|AA01}}
| PubChem = 3054
| DrugBank = APRD00920
| smiles = Oc1ccc(cc1)C(\CC)=C(/CC)c2ccc(O)cc2
| PubChem2 = 448537
| IUPHAR_ligand = 2801
| DrugBank2_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank2 = DB00255
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 731DCA35BT
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D00577
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 41922
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 411
| synonyms = DES; Stilboestrol; Stilbestrol
| C=18 | H=20 | O=2
| molecular_weight = 268.35 g/mol
| bioavailability = 
| protein_bound = 
| metabolism = Hepatic
| elimination_half-life = 
| pregnancy_category = X
| legal_status = 
| routes_of_administration = [[Intraveneous|IV]], oral
}}

'''己烯雌酚'''（{{lang-en|Diethylstilbestrol}}），非甾体[[雌激素|雌激素]]类[[药物|药物]]，于1938年首次合成。1971年，人们发现孕妇服用己烯雌酚后会导致[[畸胎|畸胎]]。

== 性质 ==
己烯雌酚为无色结晶性粉末，几乎不溶于水，溶于有机溶剂。

== 別名 ==
乙菧酚，乙烯雌酚，人造求偶素

== 临床应用 ==

1990年代，仅可证明的己烯雌酚适应症为晚期[[前列腺癌|前列腺癌]]与[[绝经|绝经]]后妇女晚期[[乳腺癌|乳腺癌]]的治疗。

最后一个生产己烯雌酚的美国制药企业-[[礼来公司|礼来公司]]在1997年停止生产销售己烯雌酚。

===不良反应===

== 生产 ==
己烯雌酚于1938年由Leon Golberg合成。

1960年代，己烯雌酚曾被用于养禽与养牛业。被证实会致癌后于1970年代停止使用。

==外部連結==
* [http://www.desaction.org/ DES Action USA] {{Wayback|url=http://www.desaction.org/ |date=20200701193608 }} and [https://web.archive.org/web/20090727173157/http://www.web.net/~desact/anglais/anglais.html DES Action Canada] offer information and resources for DES-exposed persons
* [http://www.cdc.gov/DES/ DES Update] {{Wayback|url=http://www.cdc.gov/DES/ |date=20210304221310 }} from the U.S. Centers for Disease Control and Prevention
* [https://web.archive.org/web/20070604145531/http://dccps.nci.nih.gov/ACSRB/pubs/DES_Pubs/directory.html DES Booklets] from the U.S. National Institutes of Health (circa 1980)
* [http://www.desfollowupstudy.org/ DES Follow-up Study] {{Wayback|url=http://www.desfollowupstudy.org/ |date=20110929172627 }} longterm cohort study of DES-exposed persons (including the DES-AD Project)
*[http://www.descancer.org/ DES Cancer Network] {{Wayback|url=http://www.descancer.org/ |date=20210126175140 }} offers support for DES cancer victims and their families
*[http://www.cancer.gov/ National Cancer Institutes's Cancer Information Service] {{Wayback|url=http://www.cancer.gov/ |date=20150312111454 }}
*[https://web.archive.org/web/20110721032504/http://obgyn.bsd.uchicago.edu/registry.html University of Chicago DES Registry]  of patients with CCA (clear cell adenocarcinoma) of the vagina and/or cervix.

[[Category:合成雌激素类|Category:合成雌激素类]]
[[Category:致畸原|Category:致畸原]]
[[Category:撤回药物|Category:撤回药物]]
[[Category:合成多酚类药物|Category:合成多酚类药物]]
[[Category:IARC第1类致癌物质|Category:IARC第1类致癌物质]]
[[Category:礼来公司|Category:礼来公司]]